ARCHIVES

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

This article is from The Cancer Letter archive.

Vol. 38 No. 04 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Blumenthal Says Action Plan To Issue “New Priority Areas”

October 24, 1996

Three Nurse Awards Made In Self Care

September 30, 1988

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

Donald Berry To Step Down From Departmental Posts At MD Anderson

November 26, 2010

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011

Cancer Control Budget Still $4 Million Short

January 28, 1977